Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

TELA

TELA Bio Inc

Nov 21 • 04:00PM ET

1.17

+0.11 10.38 %

Healthcare • Medical Devices • USA • NASD

Peers: MDT JNJ BSX SYK ZBH ALGN PEN GMED HOLX NKTR

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.89	Insider Own	19.49%	Shs Outstand	40.34M	Perf Week	17.08%
Market Cap	52.10M	Forward P/E	-	EPS next Y	-0.56	Insider Trans	71.02%	Shs Float	31.64M	Perf Month	-21.48%
Enterprise Value	64.41M	PEG	-	EPS next Q	-0.17	Inst Own	51.95%	Short Float	1.53%	Perf Quarter	-36.07%
Income	-39.00M	P/S	0.68	EPS this Y	38.91%	Inst Trans	-0.03%	Short Ratio	3.15	Perf Half Y	-18.75%
Sales	77.06M	P/B	30.31	EPS next Y	30.77%	ROA	-68.06%	Short Interest	0.49M	Perf YTD	-61.26%
Book/sh	0.04	P/C	1.75	EPS next 5Y	35.31%	ROE	-676.41%	52W High	3.20 -63.44%	Perf Year	-59.79%
Cash/sh	0.67	P/FCF	-	EPS past 3/5Y	16.75% 12.91%	ROIC	-90.59%	52W Low	0.86 35.34%	Perf 3Y	-85.38%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	32.99% 35.02%	Gross Margin	67.23%	Volatility	15.19% 11.39%	Perf 5Y	-92.91%
Dividend TTM	-	EV/Sales	0.84	EPS Y/Y TTM	47.45%	Oper. Margin	-46.02%	ATR (14)	0.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.62	Sales Y/Y TTM	12.24%	Profit Margin	-50.61%	RSI (14)	44.34	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	3.30	EPS Q/Q	54.89%	SMA20	-3.46%	Beta	0.90	Target Price	4.05
Payout	-	Debt/Eq	26.94	Sales Q/Q	9.14%	SMA50	-16.19%	Rel Volume	1.05	Prev Close	1.06
Employees	209	LT Debt/Eq	26.60	Earnings	Nov 13 AMC	SMA200	-28.44%	Avg Volume	153.81K	Price	1.17
IPO	Nov 08, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.50% -5.02%	Trades		Volume	161,612	Change	10.38%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-21-25	Downgrade	Piper Sandler	Overweight → Neutral	$5 → $2
May-31-22	Initiated	Lake Street	Buy	$17
Dec-03-19	Initiated	Piper Jaffray	Overweight
Dec-03-19	Initiated	JMP Securities	Mkt Outperform
Dec-03-19	Initiated	Jefferies	Buy
Dec-03-19	Initiated	Canaccord Genuity	Buy

Nov-19-25 08:30AM	TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire) -8.47%
Nov-17-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +14.08%
Nov-14-25 12:03AM	TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... (GuruFocus.com) -9.97%
Nov-13-25 05:15PM	TELA Bio, Inc. (TELA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:21PM	TELA Bio Announces Pricing of $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
04:01PM	Loading…
04:01PM	TELA Bio Reports Third Quarter 2025 Financial Results and Refinancing and Upsizing of Credit Facility (GlobeNewswire)
Nov-12-25 08:30AM	Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
07:36AM	TELA Bio Inc (TELA) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-05-25 07:10PM	Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -6.98%
Nov-04-25 08:30AM	TELA Bio to Announce Third Quarter 2025 Financial Results (GlobeNewswire) -5.84%
Nov-03-25 04:05PM	TELA Bio Appoints William Plovanic to Board of Directors (GlobeNewswire) +11.38%
Oct-09-25 04:05PM	TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran (GlobeNewswire)
Aug-12-25 03:06AM	TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com) -13.98%
Aug-11-25 07:00PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) +8.14%
04:03PM	TELA Bio Reports Second Quarter 2025 Financial Results (GlobeNewswire)
05:00PM	Loading…
Aug-08-25 05:00PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
09:31AM	TELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Aug-07-25 09:10AM	Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-06-25 08:15AM	Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -8.11%
Jul-29-25 08:15AM	NeoGenomics (NEO) Meets Q2 Earnings Estimates (Zacks)
Jul-23-25 04:03PM	TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference (GlobeNewswire)
Jul-21-25 04:03PM	TELA Bio to Announce Second Quarter 2025 Financial Results (GlobeNewswire) -7.04%
Jun-07-25 11:01PM	Aroa Biosurgery Ltd (AROAF) (FY25) Earnings Call Highlights: Surpassing Revenue Expectations ... (GuruFocus.com)
Jun-06-25 04:05PM	TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-03-25 04:05PM	TELA Bio Announces European Commercial Launch of OviTex Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair (GlobeNewswire) +10.56% +19.75%
Jun-02-25 08:30AM	TELA Bio Appoints Jeffrey Blizard as President (GlobeNewswire)
May-22-25 04:05PM	TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference (GlobeNewswire)
May-09-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +9.04% -6.48%
03:41AM	TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges (GuruFocus.com)
May-08-25 05:45PM	TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	TELA Bio Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 11:43AM	TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
Apr-21-25 04:28PM	TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ... (GuruFocus.com) -6.92% +5.62%
Apr-17-25 04:05PM	TELA Bio to Announce First Quarter 2025 Financial Results (GlobeNewswire)
Mar-31-25 07:00AM	TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex PRS for Plastic and Reconstructive Surgery (GlobeNewswire)
Mar-21-25 02:26PM	TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover (GuruFocus.com) -37.18%
12:05PM	Earnings To Watch: TELA Bio Inc (TELA) Reports Q4 2024 Result (GuruFocus.com)
Mar-20-25 10:05PM	TELA Bio sees 23-27% revenue growth for 2025 with expanded sales strategy (SeekingAlpha)
10:04PM	TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript (SeekingAlpha)
06:50PM	TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-27-25 04:05PM	TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-21-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-24-25 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-13-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Nov-19-24 04:05PM	TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference (GlobeNewswire)
Nov-08-24 12:12PM	Q3 2024 TELA Bio Inc Earnings Call (Thomson Reuters StreetEvents)
02:29AM	TELA Bio Inc (TELA) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Nov-07-24 06:20PM	TELA Bio, Inc. (TELA) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	TELA Bio Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-06-24 07:49AM	What To Expect From TELA Bio Inc (TELA) Q3 2024 Earnings (GuruFocus.com)
Nov-01-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Oct-25-24 09:05PM	OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc (GuruFocus.com) +10.85%
Oct-24-24 04:05PM	TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Oct-23-24 08:07AM	TELA Bio Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) +6.43%
Oct-22-24 04:05PM	TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Oct-17-24 04:05PM	TELA Bio to Announce Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-01-24 09:02PM	Orbimed Advisors LLC Reduces Stake in TELA Bio Inc (GuruFocus.com)
Aug-12-24 05:20PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -22.94%
04:05PM	TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance (GlobeNewswire)
Aug-09-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-25-24 04:05PM	TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Jul-22-24 04:05PM	TELA Bio to Announce Second Quarter 2024 Financial Results (GlobeNewswire)
Jun-04-24 04:05PM	TELA Bio Appoints Jeffrey Blizard to its Board of Directors (GlobeNewswire)
May-20-24 04:03PM	TELA Bio Appoints Greg Firestone as Chief Commercial Officer (GlobeNewswire)
May-13-24 11:01AM	TELA Bio, Inc. (NASDAQ:TELA) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-10-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +16.80%
03:51PM	TELA Bio Inc (TELA) Reports Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Continued Growth (GuruFocus.com)
10:15AM	Piper Sandler Adjusts Price Target on TELA Bio to $10 From $12, Maintains Overweight Rating (MT Newswires)
May-09-24 04:05PM	TELA Bio Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 04:10PM	MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript (Insider Monkey)
Apr-25-24 07:00AM	TELA Bio to Announce First Quarter 2024 Financial Results (GlobeNewswire)
Apr-15-24 07:00AM	TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR - Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures (GlobeNewswire)
Apr-08-24 07:00AM	TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy (GlobeNewswire)
Mar-22-24 09:46AM	TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript (Insider Monkey) +7.10%
07:07AM	Q4 2023 TELA Bio Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-21-24 08:53PM	TELA Stock Earnings: TELA Bio Misses EPS, Beats Revenue for Q4 2023 (InvestorPlace)
05:32PM	TELA Bio Inc Reports Robust Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
05:30PM	TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results (GlobeNewswire)
07:00AM	TELA Bio Announces U.S. Commercial Launch of LIQUIFIX the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery (GlobeNewswire)
Mar-20-24 07:00AM	TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX (GlobeNewswire)
07:00AM	MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing (GlobeNewswire)
Feb-29-24 07:00AM	TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-23-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-19-24 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.65%
Dec-15-23 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-05-23 07:00AM	TELA Bio to Take Part in Connecting the Dots (GlobeNewswire) -6.68%
Nov-16-23 07:00AM	TELA Bio to Participate in Piper Sandler's 35th Annual Healthcare Conference (GlobeNewswire)
Nov-12-23 12:20PM	TELA Bio, Inc. (NASDAQ:TELA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-10-23 04:05PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -19.37%
Nov-09-23 04:05PM	TELA Bio Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-26-23 07:00AM	TELA Bio to Announce Third Quarter 2023 Financial Results (GlobeNewswire)
Sep-18-23 04:05PM	TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase (GlobeNewswire)
Aug-16-23 07:00AM	TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery (GlobeNewswire)
Aug-11-23 10:03AM	TELA Bio, Inc. (NASDAQ:TELA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 09:18AM	Q2 2023 TELA Bio Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-09-23 06:05PM	TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:03PM	TELA Bio Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-04-23 04:02PM	TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)

TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
EW HEALTHCARE PARTNERS FUND 2,	10% Owner	Nov 17 '25	Buy	1.11	3,604,000	4,000,440	7,714,709	Nov 17 04:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Black Swan Sale

50% Off Elite

TELA

TELA Bio Inc

Upgrade your FINVIZ experience